Verrica Pharmaceuticals Inc. (VRCA) Tops Q1 EPS by 5c

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q1 EPS of ($0.38), $0.05 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $2.67 million.

For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Ennis (EBF) Reports In-Line Q1 EPS
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth